Supplementary Materials? IMCB-96-507-s001. surrogate markers might not recognize many of these cells reliably, which their quantities are regulated within an age\dependent way and correlate with V2+ and NKT T cells. V2 appearance on T cells. (b) Container?and whisker plots teaching the percentage of innate\like T\cell subsets of total Compact disc3+ T cells. MAITs the percentage of total Compact disc3+ T cells that are: (b) MAIT cells (c) Compact disc8Compact disc161 in a single cocktail, or Compact disc26 or IL\18R in another cocktail on total T cells, accompanied by MR1\5\OP\RU tetramer staining on TRAV1\2+ Compact disc161/IL\18R/Compact disc26 high, negative or FGFA intermediate Apratastat cells. (ii) Container?and whisker plots teaching percentage TRAV1\2+, Compact disc161 (green; Compact disc161 for T cell co\receptor subsets (higher -panel) and MR1\5\OP\RU tetramer staining on TRAV1\2+ Compact disc161HI cells for every co\receptor (lower -panel). (ii) Package?and whisker plots teaching percentage TRAV1\2+, Compact disc161HWe cells that are MR1\5\OP\RU tetramer+ for every co\receptor Apratastat (Compact disc4+, CD8+ and DN CD161, IL\18R or Compact disc26 on total T cells (remaining sections) or MR1\5\OP\RU tetramer+ TRAV1\2+ T cells (ideal -panel). (ii) Package?and whisker plots teaching percentage TRAV1\2+ MR1\5\OP\RU tetramer+ cells that are HI (blue), INT (Crimson) or NEG (green) for Compact disc161 (the low edge of the gate showed that as the cells with highest Compact disc161 manifestation expressed the canonical MAIT TCR\ string, the cells at the low advantage of both canonical was expressed from the Compact disc161+ cells MAIT and diverse non\MAIT TCR\ stores, helping the MR1 tetramer data teaching that this human population will not reliably represent MAIT cells (Supplementary shape 4). Upon study of additional subsets of Compact disc161HI TRAV1\2+ cells; DP, Compact disc8+, Compact disc8+ and DN T cells showed medians of 92.0% (IQR 78.5C94.4%) 94.8%, (IQR 81.5C99.7), 99.1% (IQR 97.8C99.8) and 99.0% (IQR 98.8C99.6) of MR1\5\OP\RU tetramer+ cells, respectively. Used together, as the Compact disc161HI TRAV1\2+ phenotype can be a accurate sign of Compact disc8+ and DN MAIT cells fairly, for additional MAIT cell populations (Compact disc4+, DP and Compact disc8+) this process is not extremely reliable. Next, manifestation of the popular surrogate markers on total TRAV1\2+ MR1\5\OP\RU tetramer+ MAIT cells was established (Shape?4c). Needlessly to say, the majority of MAIT cells expressed high levels of CD161, IL\18R and CD26 (medians of 97.7, 98.6 and 98.2%, respectively). Nonetheless, a small proportion of MAIT cells expressed low or intermediate levels of these markers (medians of 0.4 and 1.4%, respectively for CD161; 0.1 Apratastat and 1.3%, respectively for IL\18R; 0.4 and 1.2%, respectively for CD26) (Figure?4c ii). Analysis of co\expression of CD26 and CD161 on MAIT cells from four donors suggested that minor populations of each of CD161?CD26+, CD161+CD26? and CD161?CD26? exist, with CD26?CD161+ being the most prominent of the three populations (Supplementary figure 5a). From two of these donors, we detected a clear subpopulation of TRAV1\2+ MR1\5\OP\RU tetramer+ MAIT cells that were negative for CD26, and in one donor these cells expressed lower levels of CD161 compared to the rest of the MAIT population, as well as being CD27?CD28?Tbet? (Supplementary figure 5a, donor D3 and Supplementary figure 5b). This highlights that while in most cases, the surrogate markers, particularly CD161, accurately identify most MAIT cells, not all MAIT cells are identified with this approach, and in some outlying individuals these markers can be highly inaccurate. Thus, while the combination of CD161 and TRAV1\2 identifies the great majority of MAIT cells, not all CD161+ T cells are MAIT cells and not all MAIT cells are identified with these markerstests. MAIT cell subset cytokine production To determine whether a similar proportion of MAIT cells in each subset could produce cytokines, healthy PBMCs were stimulated with phorbol 12\myristate 13\acetate (PMA) and ionomycin for 7?h prior to intracellular cytokine staining for IFN and TNF (Figure?6c). No significant differences in ability to produce TNF or IFN were observed between any of these subsets. In order to examine a broader array of cytokines, MAIT.